CRC - Insulin Resistance and Insulin Resistance Syndrome
| Organization: | CRC |
| Publication Date: | 29 August 2002 |
| Page Count: | 385 |
scope:
PREFACE
In 1936, Himsworth (Himsworth, 1936) observed that some diabetic patients require increasing amounts of insulin, and appear to become gradually insensitive to insulin, or "resistant" to the actions of insulin. Today, the term "insulin resistance" is applied to a broad range of biological observations, with an equally wide variety of potential underlying mechanisms. Animal models are being extensively used to examine both the causes of loss of insulin sensitivity, and the potential for reversal of this loss.
Consensus has not yet developed around a specific and quantifiable definition of insulin resistance. Most commonly, the presence of insulin resistance has been inferred when a given amount of endogenous or exogenous insulin has shown less than its expected biological action. In truth, insulin resistance is substantially related to the methods used to seek it, and the methods today differ widely from in vitro cellular methods to whole body euglycemic or hyperglycemic clamps. Over the past twenty years the so-called "gold standard" for measuring in vivo (whole body) insulin resistance has been this "clamp", as developed initially by DeFronzo, Tobin, and Andres (DeFronzo et al., 1979). During the earliest phases in the development of type 2 diabetes, insulin resistance gradually develops, accompanied by increasing fasting hyperinsulinemia and increasing beta cell responsiveness to a glucose stimulus.
Animal models of obesity and diabetes have contributed to
understanding the natural history of the development of insulin
resistance and to identifying some of the factors underlying this
insulin resistance. In the present volume, we have drawn together
some of the leaders in the field who provide their perspectives on
the mechanisms of insulin resistance, as discerned from various
animal models. While the exact mechanism underlying the appearance
of resistance to insulin remains unknown, the authors here have
examined many of the important factors. The contribution of age,
from early perinatal to aged adulthood, has been considered.
Insulin resistance is a major feature of the middle-aged onset,
obesity-associated Metabolic Syndrome, sometimes referred to as
Diabesity (Shafrir, 1993), diabetogenic obesity (Vague, 1956), or
syndrome X (Reaven, 1988). This syndrome, described by many
clinicians and investigators beginning nearly fifty years ago
(Vague, 1956), derives from observation of the frequent
interactions of insulin resistance with obesity, dyslipidemia,
glucose intolerance, cardiovascular disease, hypertension, and
abnormalities in whole body metabolism, as previously reviewed
(Hansen, 1999). These clinical features and their possible insulin
resistanceassociated